Trials / Terminated
TerminatedNCT03011749
Value of FLT PET/CT in Radium-223 Therapy of mCRPC Patients
Value of FLT PET/CT in Radium-223 Therapy of Patients With Metastatic Castration-resistant Prostate Cancer
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Rigshospitalet, Denmark · Academic / Other
- Sex
- Male
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of the study is to investigate whether positron emission tomography (PET) using the tracer 18F-Fluorothymidine (FLT) can provide information on proliferative activity in bone marrow of patients receiving Radium 223 therapy and potentially be a predictive marker of hematological toxicity
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | FLT PET/CT | FLT PET/CT before first series of Radium-223 and after 2 series |
Timeline
- Start date
- 2017-01-01
- Primary completion
- 2018-02-01
- Completion
- 2018-02-01
- First posted
- 2017-01-05
- Last updated
- 2019-09-12
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT03011749. Inclusion in this directory is not an endorsement.